Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

Authors: R Rettl, T Wollenweber, C Mann, F Duca, T.-M Dachs, C Binder, M Stojanovic, L Camuz Ligios, L Schrutka, D Dalos, S Charwat-Resl, R Badr Eslam, J Kastner, M Hacker, D Bonderman

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.1811

Source: Full article

Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

Abstract